Our Top 15 Most-Clicked Stories of 2022
Thanks for joining us in Year 1 of Bio.News. We published over 700 stories in less than one year – and these were the […]
Our Top 15 Most-Clicked Stories of 2022 Read More »
Thanks for joining us in Year 1 of Bio.News. We published over 700 stories in less than one year – and these were the […]
Our Top 15 Most-Clicked Stories of 2022 Read More »
The Centers for Disease Control and Prevention (CDC) said updated COVID-19 booster vaccines have improved Americans’ resistance against severe COVID, lowering the probability of
Updated COVID boosters slash hospitalization risk by 50% Read More »
The U.S. Food and Drug Administration (FDA) approved Genentech’s Actemra to treat COVID-19 in hospitalized adults. The drug is approved for adults “receiving systemic
FDA approves first monoclonal antibody to treat COVID-19 Read More »
The United States and the Biotechnology Innovation Organization (BIO) have been taking action in light of ongoing negotiations concerning extending the Trade-Related Aspects of
What’s happening with the COVID IP waiver expansion? Read More »
The Senate on Wednesday confirmed Alexis Taylor to become the U.S. Department of Agriculture (USDA) undersecretary for trade and foreign agricultural affairs. The USDA
Senate confirms Alexis Taylor as USDA trade undersecretary Read More »
The text of the 4,155-page, $1.7 trillion omnibus spending bill was delivered around 2 a.m. Tuesday. According to POLITICO, the Senate is “scrambling” to
What’s in the government’s omnibus spending package Read More »
It’s no surprise the COVID-19 pandemic aggravated the United States’ already rampant opioid epidemic. But what’s more surprising, and devastating, has been the increase
Teen opioid deaths are on the rise – but OTC Narcan could help Read More »
The federal government today released two calls for public input on how the U.S. can support biotech innovation to help strengthen the industry while
Biden Administration seeks public input on how to support biotech Read More »
On Friday, Mexican officials proposed amendments to the plan to ban imports of biotech corn from the U.S. and said they expect to reach
Mexico proposes amendments to biotech corn ban Read More »
The process of holding clinical trials and gaining FDA approval takes up much of the time and expense involved in drug development, which can
BIO aids global harmonization, helping speed cures to patients Read More »